Kim et al. showed that blocking TLR2 reduced αSyn accumulation in neuronal and astroglial cells, neuroinflammation, neurodegeneration, and functional deficits in a PD mouse model [157]. The gene discussed is TLR2; the disease is Parkinson disease.